| Structure | Chemical Name | CAS | MF |
|
tendamistat (12-26)
|
135307-06-1
|
C79H114N22O26
|
|
Cyclopropanol, 1-methoxy-2,3-bis(1-methylethyl)- (9CI)
|
135307-42-5
|
C10H20O2
|
|
3-Azatricyclo[3.2.1.02,4]octane-3-butanamine,(1-alpha-,2-bta-,4-bta-,5-alpha-)-(9CI)
|
135308-70-2
|
C11H20N2
|
|
D,L N,O-Didesmethylvenlafaxine
|
135308-74-6
|
C15H23NO2
|
|
D,L-N,N-Didesmethyl-O-desmethyl Venlafaxine Hydrochloride
|
135308-76-8
|
C14H22ClNO2
|
|
8(5H)-Isoquinolinone, 6,7-dihydro-, hydrochloride
|
135311-97-6
|
C9H10ClNO
|
|
2-BROMOTETRADECANOIC ACID
|
135312-82-2
|
C14H27BrO2
|
|
DEAMINO-TYR-TYR ETHYL ESTER
|
135313-59-6
|
C20H23NO5
|
|
4-CHLORO-3-INDOLYL BETA-D-GALACTOPYRANOSIDE
|
135313-63-2
|
C14H16ClNO6
|
|
stage-specific elongation factor, developmental
|
135314-80-6
|
|
|
|
nolA protein
|
135315-83-2
|
|
|
|
fs(1)Ya protein
|
135315-84-3
|
|
|
|
tsh protein
|
135315-85-4
|
|
|
|
ToxS protein
|
135315-97-8
|
|
|
|
alpha 1-antitrypsin binding protein 1
|
135315-99-0
|
|
|
|
alpha 1-antitrypsin binding protein 2
|
135316-00-6
|
|
|
|
sds22+ protein
|
135316-05-1
|
|
|
|
peptide methionine-tyrosine
|
135316-81-3
|
|
|
(2RS,3SR)-1-[3-(2-chlorophenyl)-2,3-epoxy-2-(4-fluorophenyl)propyl]-1H-1,2,4-triazole
|
135319-73-2
|
C17H13ClFN3O
|
|
Methyl 4-(N-(tert-butoxycarbonyl)carbaMiMidoyl)benzoate
|
135321-84-5
|
C14H18N2O4
|
|
5-(N-TERT-BUTOXYCARBONYLAMINO)SALICYLIC ACID
|
135321-95-8
|
C12H15NO5
|
|
3-(BOC-AMINO)-4-HYDROXYBENZOIC ACID
|
135322-01-9
|
C12H15NO5
|
|
1-(Aminoiminomethyl)-4-piperidinecarboxylic acid
|
135322-16-6
|
C7H13N3O2
|
|
|
CHITOSAN ASCORBATE
|
135322-32-6
|
|
|
2-CHLORO-4-(MORPHOLIN-4-YLCARBONYL)QUINOLINE
|
135323-95-4
|
C14H13ClN2O2
|
|
1-Pyrrolidinamine,2-methyl-,(R)-(9CI)
|
135324-43-5
|
C5H12N2
|
|
(R)-2-Methylpyrrolidine hydrochloride
|
135324-85-5
|
C5H12ClN
|
|
1,2,3,4,5,6-Hexahydropyrrolo[3,4-c]pyrrole dihydrobromide
|
135325-05-2
|
C6H11BrN2
|
|
1,2,3,4,5,6-hexahydropyrrolo[3,4-c]pyrrole
|
135325-06-3
|
C6H10N2
|
|
Benzeneacetic acid, 4-(trifluoroMethyl)-, Methyl ester
|
135325-18-7
|
C10H9F3O2
|
|
1-nitro-2-methyl-4-aminopyrrole
|
135325-54-1
|
C5H7N3O2
|
|
1-BROMOMETHYLFLUORANTHENE
|
135325-62-1
|
|
|
Gadoxetic acid
|
135326-11-3
|
C23H30GdN3O11
|
|
GADOXETATE DISODIUM
|
135326-22-6
|
C23H28GdN3NaO11-
|
|
PROPYLENE GLYCOL MYRISTYL ETHER ACETATE
|
135326-54-4
|
C19H38O3
|
|
CLARITHROMYCIN LACTOBIONATE
|
135326-55-5
|
C50H89NO24
|
|
1(3)-pyrenebutanoyl-2,3(1,2)-dipalmitoyl-sn-glycerol
|
135328-05-1
|
C55H82O6
|
|
7-BENZHYDRYLOXYINDOLE
|
135328-49-3
|
C21H17NO
|
|
7-(CYANOMETHOXY)INDOLE
|
135328-50-6
|
C10H8N2O
|
|
8-HYDROXY-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE
|
135329-20-3
|
C9H9NO2
|
|
3-methoxy-2-methylbenzamide
|
135329-22-5
|
C9H11NO2
|
|
Benzamide, 3-hydroxy-2-methyl- (9CI)
|
135329-26-9
|
C8H9NO2
|
|
cyclo(asparaginyl-threonyl-seryl-phenylalanyl-threonyl-prolyl-arginyl-leucyl)
|
135329-52-1
|
C41H64N12O12
|
|
Ethanediimidamide, N,N-dihydroxy-N-2-pyridinyl-, (Z,Z)- (9CI)
|
135329-77-0
|
C7H9N5O2
|
|
2 4-DIETHOXYBENZOPHENONE 97
|
135330-07-3
|
C17H18O3
|
|
diazipine
|
135330-18-6
|
C29H26F6N4O5
|
|
3-(2-trifluoromethylbenzylamino)-2-benzhydrylquinuclidine
|
135330-43-7
|
C28H29F3N2
|
|
1-(2-(2,4-Dichlorophenyl)-2-(geranyloxy)ethyl)-1H-imidazole
|
135330-85-7
|
C21H26Cl2N2O
|
|
2-bromo-2-methoxypropiophenone
|
135333-25-4
|
C10H11BrO2
|
|
1-(5-HYDROXY-1,2-DIMETHYL-1H-INDOL-3-YL)-ETHANONE
|
135333-93-6
|
C12H13NO2
|
|
Ethyl 2-(3-chlorophenyl)-2,2-difluoroacetate
|
135334-14-4
|
C10H9ClF2O2
|
|
3-Isoxazolecarbonyl chloride, 5-(dichloromethyl)- (9CI)
|
135335-77-2
|
C5H2Cl3NO2
|
|
Ethyl, 2-(dimethylamino)-1-phenyl-2-thioxo- (9CI)
|
135339-79-6
|
C10H12NS
|
|
2-Bromo-6-chloro-4-methylaniline
|
135340-78-2
|
C7H7BrClN
|
|
A-L HYDROCHLORIDE
|
135340-91-9
|
C9H21N3O4
|
|
|
acyl carrier protein II
|
135343-52-1
|
|
|
|
Tetrahymena 14-nm filament-forming protein
|
135343-59-8
|
|
|
5-[[(1,1-DiMethylethoxy)carbonyl]aMino]-2-(phenylMethoxy)-benzoic Acid PhenylMethyl Ester
|
135345-41-4
|
C26H27NO5
|
|
1,3,5-Cycloheptatriene-1-carboxylicacid,6-hydrazino-7-oxo-,methylester
|
135345-77-6
|
C9H10N2O3
|
|
1,3,5-Cycloheptatriene-1-carboxylicacid,6-(2-methylhydrazino)-7-oxo-,methyl
|
135345-81-2
|
C10H12N2O3
|
|
Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-4,9-dimethyl- (9CI)
|
135347-92-1
|
C13H16N2
|
|
Ethanone, 1-(4,5-dihydro-2-methyl-3-furanyl)-2,2,2-trifluoro- (9CI)
|
135351-21-2
|
C7H7F3O2
|
|
2-Acetyl-3,4-dihydroxy-5-methoxyphenylacetic acid
|
135351-78-9
|
C11H12O6
|
|
5-IODO-3,7-DIHYDRO-PYRROLO[2,3-D]PYRIMIDIN-4-ONE
|
135352-71-5
|
C6H4IN3O
|
|
5-IODO-2-METHYL-3,7-DIHYDRO-PYRROLO[2,3-D]PYRIMIDIN-4-ONE
|
135352-75-9
|
C7H6IN3O
|
|
1,3,3-Trimethyl-2-oxindole-6-carboxylic acid
|
135354-00-6
|
C12H13NO3
|
|
Xaliproden
|
135354-02-8
|
C24H22F3N
|
|
Methyltanshinonate
|
135355-72-5
|
C20H18O5
|
|
(E)-4-TERT-BUTOXY-4-OXOBUT-2-ENOIC ACID
|
135355-96-3
|
C8H12O4
|
|
2',3'-dideoxytiazofurin
|
135355-98-5
|
C18H26N4O7S2
|
|
ganosporeric acid A
|
135357-25-4
|
C30H38O8
|
|
3-Oxatricyclo[3.2.1.02,4]octane-6-carboxylicacid,[1R-(1alpha,2beta,4beta,5alpha,6alpha)]-(9CI)
|
135357-67-4
|
C8H10O3
|
|
Restricticin
|
135357-96-9
|
C19H31NO4
|
|
Butanoic acid, 2-fluoro-3-Methyl-, Methyl ester
|
135359-27-2
|
C6H11FO2
|
|
(δR,1R,3aR,4S,7aR)-Octahydro-4-hydroxy-δ,7a-dimethyl-1H-indene-1-pentanoic Acid Methyl Ester
|
135359-40-9
|
C17H30O3
|
|
[1R-[1α(R*),3aβ,7aα]]-Octahydro-δ,7a-dimethyl-4-oxo-1H-indene-1-pentanoic Acid Methyl Ester
|
135359-41-0
|
C17H28O3
|
|
(3β,5Z,7E)-3-(tert-Butyldimethylsiluloxy)-9,10-secochola05,7,10(19)-triene-24-carboxylic Acid Methyl Ester
|
135359-42-1
|
C32H54O3Si
|
|
1H-1,2-Diazepine-1-carboxylicacid,methylester(9CI)
|
135360-85-9
|
C7H8N2O2
|
|
6-deoxyerythromycin A
|
135361-13-6
|
C37H67NO12
|
|
ISOQUINOLIN-7-YL TRIFLUOROMETHANESULFONATE
|
135361-30-7
|
C10H6F3NO3S
|
|
3-(4-Methoxybenzyloxy)-1-propanol
|
135362-69-5
|
C11H16O3
|
|
(R)-2-HYDROXY-2-METHYL-HEPTANENITRILE
|
135362-75-3
|
C8H15NO
|
|
9-N,N-dimethylamino-9-deoxy-10,11,12,13-tetrahydroniddamycin
|
135363-57-4
|
C42H76N2O13
|
|
9-((2-hydroperoxy-3-methyl-3-butenyl)oxy)-7H-furo(3,2-g)(1)benzopyran-7-one
|
135366-51-7
|
C16H14O6
|
|
2(3H)-Furanone, 3-acetyldihydro-3-hydroxy- (9CI)
|
135366-64-2
|
C6H8O4
|
|
3β-(4-Iodophenyl)tropane-2β-carboxylic acid Methyl ester
|
135367-08-7
|
C16H20BrNO2
|
|
Ethanone, 1-(5-ethyltetrahydro-2-methyl-3-furanyl)-, (2alpha,3alpha,5alpha)- (9CI)
|
135367-27-0
|
C9H16O2
|
|
Ethanone, 1-(5-ethenyltetrahydro-2-methyl-3-furanyl)-, (2alpha,3alpha,5alpha)- (9CI)
|
135367-30-5
|
C9H14O2
|
|
Ethanone, 1-(5-ethyltetrahydro-2-methyl-3-furanyl)-, (2alpha,3beta,5alpha)- (9CI)
|
135367-31-6
|
C9H16O2
|
|
Ethanone, 1-[tetrahydro-5-(hydroxymethyl)-2-methyl-3-furanyl]-, [2S-
|
135367-52-1
|
C8H14O3
|
|
FLUORESCEIN DI-P-GUANIDINOBENZOATE HYDROCHLORIDE
|
135367-80-5
|
C36H27ClN6O7
|
|
4-(P-DIHEXADECYLAMINOSTYRYL)-N-METHYLQUINOLINIUM IODIDE
|
135367-81-6
|
C50H81IN2
|
|
tetrahydro-3-oxo-2H-thiopeyran-4-carboxylic acid ethyl ester
|
135369-32-3
|
C8H12O3S
|
|
|
hemoglobin Davenport
|
135371-20-9
|
|
|
|
PROTEINGERANYLGERANYLTRANSFERASE
|
135371-29-8
|
|
|
|
self incompatibility associated protein S3, Solanum chacoense
|
135374-33-3
|
|
|
|
self-incompatibility associated protein S2, Solanum chacoense
|
135374-34-4
|
|
|
maxadilan
|
135374-80-0
|
C291H465N85O95S6
|
|
|
VinaSoft
|
135375-67-6
|
|
|
5H-Pyrazolo[4,3-d]pyrimidin-5-one, 1,4,6,7-tetrahydro-4-methyl-
|
135376-98-6
|
C6H8N4O
|